Finlo Pharmaceuticals Private Limited
About Finlo Pharmaceuticals Private Limited
Data last updated:
Finlo Pharmaceuticals Private Limited was a private limited company based in Guwahati, Assam, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 11 September 2020.
The company was registered with the Registrar of Companies (ROC), Guwahati, under CIN U51909AS2020PTC020453.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It was led by directors Kamlesh Jain and Kamal Paul.
Its last annual general meeting (AGM) was held on 31 December 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at C/O Kamal Paul Lachit Path Odalbakhra, Guwahati, Assam, India – 781034.
As per the financials filed for FY 2021, the company reported a revenue of ₹11.68 Lakh. For the same year it recorded a net profit of ₹1,068 (net margin 0.1%) and EBITDA of ₹4,281 (EBITDA margin 0.4%).
Company details
Contact details
Finlo Pharmaceuticals Private Limited's registered office is in Guwahati, Assam.
- Registered AddressC/O Kamal Paul Lachit Path Odalbakhra, Guwahati, Assam, India – 781034
- IndustryTrading, Wholesale, Specialty
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Finlo Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Finlo Pharmaceuticals Private Limited, buy the company report.
Financials of Finlo Pharmaceuticals Private Limited
FY 2021 filings availableFinlo Pharmaceuticals Private Limited reported revenue of ₹11.68 Lakh for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹4,281 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹1,068 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2020-21 |
|---|---|
| Profitability | |
| EBITDA Margin | 0.4% |
| Net Profit Margin | 0.1% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Finlo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Finlo Pharmaceuticals Private Limited
Finlo Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamlesh Jain | Director | 11 Sep 2020 | 6 Years 1 Months | As last reported |
| Kamal Paul Also directs: Vidyaamrit Foundation | Director | 11 Sep 2020 | 6 Years 1 Months | As last reported |
Peer comparison
Finlo Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chairo Pharmaceuticals Private Limited | ₹11.71 Lakh (FY 2025) | 56.0% | Pune, Maharashtra, India | |||
| Prowell Pharmaceuticals Private Limited | ₹11.71 Lakh (FY 2024) | -6.0% | Kalol, Gujarat, India | |||
| Newzen Pharmaceuticals Private Limited | ₹11.7 Lakh (FY 2020) | -38.0% | Delhi, India | |||
| Western Indian Pharmaceuticals (OPC) Private Limited | ₹11.69 Lakh (FY 2025) | -8.0% | Indore, Madhya Pradesh, India | |||
| Finlo Pharmaceuticals Private Limitedthis company | ₹11.68 Lakh (FY 2021) | ₹1,068 | 0.1% | Guwahati, Assam, India | ||
| Confiance Pharmaceuticals Private Limited | ₹11.67 Lakh (FY 2025) | -15.0% | Madhubani, Bihar, India | |||
| Alexa Pharmaceuticals Private Limited | ₹11.59 Lakh (FY 2019) | -27.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Finlo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Finlo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Finlo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Finlo Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Finlo Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Amit Pandya ceased to be Director on 23 May 2022.
Frequently asked questions
Finlo Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Finlo Pharmaceuticals was a private limited company based in Guwahati, Assam, India. The company worked in wholesale, within the trading industry. It was incorporated on 11 September 2020 and is registered under CIN U51909AS2020PTC020453. The company has been struck off by the Registrar of Companies and is no longer operational.
Finlo Pharmaceuticals had 2 directors:
- Kamlesh Jain - Director
- Kamal Paul - Director
The CIN (Corporate Identification Number) of Finlo Pharmaceuticals is U51909AS2020PTC020453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Finlo Pharmaceuticals is at CO Kamal Paul Lachit Path Odalbakhra, Guwahati, Assam, India – 781034.
Finlo Pharmaceuticals was incorporated on 11 September 2020. It is registered with the Registrar of Companies, Guwahati.
The latest financial statements of Finlo Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 31 December 2021. Year-wise statements from FY 2021 are in the company report.
Finlo Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
The peers of Finlo Pharmaceuticals by revenue are Chairo Pharmaceuticals Private Limited, Prowell Pharmaceuticals Private Limited, Newzen Pharmaceuticals Private Limited, Western Indian Pharmaceuticals (OPC) Private Limited, Confiance Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Pandya ceased to be Director on 23 May 2022. Kamal Paul was appointed as Director on 11 Sep 2020. Kamlesh Jain was appointed as Director on 11 Sep 2020.
Finlo Pharmaceuticals can be reached at its registered office: CO Kamal Paul Lachit Path Odalbakhra, Guwahati, Assam, India – 781034.